ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sphere of biopharmaceuticals, providing promising developments throughout many health-related and industrial purposes. With its structural similarity to Normally derived human serum albumin, OsrHSA offers a safer, far more reputable substitute for therapeutic us